Chimerix (CMRX)
(Delayed Data from NSDQ)
$0.95 USD
0.00 (0.28%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.95 0.00 (-0.30%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 40% (151 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.69 | 9.99 |
Current Quarter Estimate | -0.22 | 5.88 | 57.00 |
Year Ago Quarter Estimate | -0.21 | 4.88 | 52.54 |
Next Quarter Estimate | -0.25 | 7.06 | 61.00 |
Next Year Estimate | -0.98 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 12.90 | 18.40 | 15.67 |
Next Year | -20.99 | 24.30 | 9.31 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 10.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 0.49 | 1.90 |
Price/Cash Flow (MRFY) | NA | 10.67 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -25,337.96% | 12.53% |
Return on Equity (TTM) | -41.32% | 13.71% |
Debt to Equity (MRQ) | 0.00 | 19.86 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.